ES395573A1 - Procedimiento para la obtencion de preparados farmaceuti- cos. - Google Patents
Procedimiento para la obtencion de preparados farmaceuti- cos.Info
- Publication number
- ES395573A1 ES395573A1 ES395573A ES395573A ES395573A1 ES 395573 A1 ES395573 A1 ES 395573A1 ES 395573 A ES395573 A ES 395573A ES 395573 A ES395573 A ES 395573A ES 395573 A1 ES395573 A1 ES 395573A1
- Authority
- ES
- Spain
- Prior art keywords
- arylamino
- chloroethyl
- pharmaceutical preparations
- formula
- toluidinomethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- -1 tetralyl Chemical group 0.000 abstract 8
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001769 aryl amino group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- PDDQPUUOEBGDSN-UHFFFAOYSA-N 1,4-bis(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)piperazine Chemical compound C1OC2=CC=CC=C2OC1CN(CC1)CCN1CC1OC2=CC=CC=C2OC1 PDDQPUUOEBGDSN-UHFFFAOYSA-N 0.000 abstract 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 abstract 1
- QZVCTJOXCFMACW-UHFFFAOYSA-N Phenoxybenzamine Chemical compound C=1C=CC=CC=1CN(CCCl)C(C)COC1=CC=CC=C1 QZVCTJOXCFMACW-UHFFFAOYSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000005133 alkynyloxy group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- NYGHGTMKALXFIA-UHFFFAOYSA-N azapetine Chemical compound C1N(CC=C)CC2=CC=CC=C2C2=CC=CC=C21 NYGHGTMKALXFIA-UHFFFAOYSA-N 0.000 abstract 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- PBUNVLRHZGSROC-VTIMJTGVSA-N dihydro-alpha-ergocryptine Chemical compound C1=CC([C@H]2C[C@H](CN(C)[C@@H]2C2)C(=O)N[C@]3(C(=O)N4[C@H](C(N5CCC[C@H]5[C@]4(O)O3)=O)CC(C)C)C(C)C)=C3C2=CNC3=C1 PBUNVLRHZGSROC-VTIMJTGVSA-N 0.000 abstract 1
- LIMAOLZSWRJOMG-HJPBWRTMSA-N dihydroergocristine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](C(N21)=O)(NC(=O)[C@H]1CN(C)[C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C(C)C)C1=CC=CC=C1 LIMAOLZSWRJOMG-HJPBWRTMSA-N 0.000 abstract 1
- 229960004318 dihydroergocristine Drugs 0.000 abstract 1
- 229960002032 dihydroergocryptine Drugs 0.000 abstract 1
- HESHRHUZIWVEAJ-JGRZULCMSA-N dihydroergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C)C1=CC=CC=C1 HESHRHUZIWVEAJ-JGRZULCMSA-N 0.000 abstract 1
- 229960004704 dihydroergotamine Drugs 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1461470 | 1970-10-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES395573A1 true ES395573A1 (es) | 1974-12-01 |
Family
ID=4402343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES395573A Expired ES395573A1 (es) | 1970-10-02 | 1971-09-30 | Procedimiento para la obtencion de preparados farmaceuti- cos. |
Country Status (10)
| Country | Link |
|---|---|
| AU (1) | AU464325B2 (enrdf_load_stackoverflow) |
| BE (1) | BE773408A (enrdf_load_stackoverflow) |
| CA (1) | CA960141A (enrdf_load_stackoverflow) |
| DE (1) | DE2147711A1 (enrdf_load_stackoverflow) |
| ES (1) | ES395573A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2112248B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1369821A (enrdf_load_stackoverflow) |
| IL (1) | IL37700A (enrdf_load_stackoverflow) |
| NL (1) | NL7113533A (enrdf_load_stackoverflow) |
| ZA (1) | ZA716148B (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ179623A (en) * | 1975-01-06 | 1978-03-06 | Ciba Geigy | Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund |
-
1971
- 1971-09-13 IL IL37700A patent/IL37700A/xx unknown
- 1971-09-14 CA CA122,764A patent/CA960141A/en not_active Expired
- 1971-09-14 ZA ZA716148A patent/ZA716148B/xx unknown
- 1971-09-15 GB GB4298371A patent/GB1369821A/en not_active Expired
- 1971-09-24 DE DE19712147711 patent/DE2147711A1/de active Pending
- 1971-09-30 FR FR7135265A patent/FR2112248B1/fr not_active Expired
- 1971-09-30 ES ES395573A patent/ES395573A1/es not_active Expired
- 1971-09-30 AU AU34050/71A patent/AU464325B2/en not_active Expired
- 1971-10-01 NL NL7113533A patent/NL7113533A/xx unknown
- 1971-10-01 BE BE773408A patent/BE773408A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3405071A (en) | 1973-04-05 |
| CA960141A (en) | 1974-12-31 |
| FR2112248B1 (enrdf_load_stackoverflow) | 1975-04-18 |
| BE773408A (fr) | 1972-04-04 |
| ZA716148B (en) | 1972-05-31 |
| AU464325B2 (en) | 1975-08-21 |
| DE2147711A1 (de) | 1972-04-06 |
| NL7113533A (enrdf_load_stackoverflow) | 1972-04-05 |
| FR2112248A1 (enrdf_load_stackoverflow) | 1972-06-16 |
| IL37700A0 (en) | 1971-11-29 |
| IL37700A (en) | 1975-05-22 |
| GB1369821A (en) | 1974-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910006241A (ko) | 피리미딘-4,6-디카복실산 디아미드, 이의 제조방법, 이의 용도 및 이들 화합물을 기초로 하는 약제 | |
| ES539565A0 (es) | Un procedimiento para preparar derivados de imidazol | |
| NO800447L (no) | Derivater av difenylhydantoin, farmasoeytiske preparater inneholdende slike preparater, samt fremgangsmaate til fremstilling av de aktive forbindelser | |
| DK12087D0 (da) | Decahydroquinolinderivater, deres fremstilling og anvendelse samt praeparater med indhold deraf | |
| SE8104515L (sv) | Nya 4h-1,2,4-triazolderivat, sett for framstellning och anvendning derav sasom lekemedel, kompositioner innehallande dessa foreningar samt de erhallna mellanprodukter | |
| ES526089A0 (es) | Un procedimiento para preparar derivados de ciclobutano | |
| ES395573A1 (es) | Procedimiento para la obtencion de preparados farmaceuti- cos. | |
| GB1527543A (en) | Basically substituted xanthine derivatives | |
| ES388761A1 (es) | Procedimiento para la obtencion de 3,4-dihidro-quinazolino-nas. | |
| MX9305300A (es) | Nuevos derivados de 3-oxadiazolil-1-6-naftiridina y proceso para supreparacion. | |
| ES499393A0 (es) | Procedimiento para preparar nuevos derivados de triazoloqui-nazolinona | |
| ES419019A1 (es) | Procedimiento para la preparacion de compuestos polici- clicos. | |
| ES523797A0 (es) | Procedimiento para la obtencion de b-lactamantibioticos. | |
| ES338416A1 (es) | Un procedimiento para la preparacion de un compuesto deri- vado de carbazol. | |
| GB1321368A (en) | Organo-phosphorus compounds useful for the control of helminths in warm-blooded animals | |
| SE7409378L (enrdf_load_stackoverflow) | ||
| CU21558A3 (en) | Obtainment procedure of acrydanone | |
| ES316532A1 (es) | Procedimiento para la obtenciën de nuevos seudo-indoles sustituidos basicamente | |
| ES404401A1 (es) | Procedimiento para la obtencion de sales farmaceuticamente aceptables de derivados de aza-8 purinonas-6. | |
| IL70103A0 (en) | Semicarbazides,their preparation and pharmaceutical compositions containing them | |
| GB1153131A (en) | Pharmaceutical Compositions | |
| ES8206515A1 (es) | Procedimiento para la preparacion de derivados de imidazol | |
| GB1059182A (en) | Dibenzodiazepine derivatives and the manufacture thereof |